Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease

Abstract

Get full access to this article

View all access options for this article.

References

1 Peltola, H. , Kayhty, H. , Sivonen, A. and Makela, P.H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees three months to five years of age in Finland. Pediatrics , 1977; 60: 730-737.

Dajani, S.A. , Asmar, I.B. and Thirumoorthi , C.M. Systemic Haemophilus influenzae disease. J. Pediatr., 1979; 94: 355-364.

Sell, S.H. , Merrill, R.E. , Doyne, E.O. and Zimsky, E.P. Long-term sequelae ofHaemophilus influenzae meningitis. Pediatrics, 1972; 49: 206-211.

Jadavji, T. , Biggar, W.D. , Gold, R. and Prober, C.G. Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics , 1986; 78: 21-25.

Sell, S.H. Long-term sequelae of bacterial meningitis in children. Pediatr. Infect. Dis., 1983; 2: 90-3.

Conchi, S.L. , Broome, C.V. and Hightower , A.W. Assessment of strategies for immunisation of US children with H. influenzae type b polysaccharide vaccine: A cost effectiveness model. JAMA , 1985; 253: 521-529.

Peltola, H. , Kayhty, H. , Virtanen, M. and Makela, P.H. Prevention of Haemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N. Engl. J. Med., 1984; 310: 1561-1566.

American Academy of Pediatrics, Committee on Infectious Diseases. Revision of recommendation for use of rifampin prophylaxis of contacts of patients with Haemophilus influenzae infection. Pediatrics, 1984 ;74:301-302.

Black, S.B. and Shinefield , H.R. , and the Northern California Permanente Medical Care Program Departments of Pediatrics Vaccine Study Group. b-CAPSA Haemophilus influenzae, type b, capsular polysaccharide vaccine safety. Pediatrics , 1987; 79: 321-325.

10.

American Academy of Pediatrics, Committee on Infectious Diseases. Haemophilus type b polysaccharide vaccine . Pediatrics, 1985; 76: 322-324.

11.

Cates, K.L. Haemophilus influenzae type b polysaccharide vaccine. Pediatr. Ann., 1986 ;15: 461-468.

12.

Ward, J. , Berkowitz, C. , Pescetti, J. , Berkart, K. , Samuelson, J. and Gordon, L. Enhanced immunogenicity in young infants of a new Haemophilus influenzae type b (Hib) capsular polysaccharide (PRP)-

13.

dipthenc toxoid (D) conjugate vaccine. Pediatr. Res., 1984;18: 287A.

14.

Zahraknik, J.M. and Gordon, L.K. Augmented antibody (Ab) responses in infants administered a new Haemophilus influenzae type b capsular polysaccharide (PRP) diptheric toxoid conjugate vaccine (PRP-D). Pediatr. Res., 1984; 18 : 289A.

15.

Eskola, J. , Peltola, H. , Takala, A.K. , Kayhty, H. , Hakulinen, M. , Karanko, V. , Kela, E. , Rekola, P. , Ronnberg, P.R. , Samuelson, J.S. , Gordon , L.K. and Makela, P.H. Efficacy of Haemophilus influenzae type b polysaccharide-diptheria toxoid conjugate vaccine in infancy. N. Engl. J. Med., 1987; 317: 717-722.